DSAM Partners (London) Ltd - Q3 2021 holdings

$176 Million is the total value of DSAM Partners (London) Ltd's 18 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .

 Value Shares↓ Weighting
ARYD ExitARYA SCIENCES ACQU CORP IVcl a$0-20,000
-100.0%
-0.04%
AFIB ExitACUTUS MED INC$0-71,848
-100.0%
-0.20%
EXP ExitEAGLE MATLS INC$0-9,609
-100.0%
-0.23%
APLT ExitAPPLIED THERAPEUTICS INC$0-67,125
-100.0%
-0.23%
NEXI ExitNEXIMMUNE INC$0-89,500
-100.0%
-0.24%
SUM ExitSUMMIT MATLS INCcl a$0-43,741
-100.0%
-0.26%
OVV ExitOVINTIV INC$0-51,800
-100.0%
-0.27%
OPCH ExitOPTION CARE HEALTH INC$0-74,583
-100.0%
-0.27%
CVE ExitCENOVUS ENERGY INC$0-171,000
-100.0%
-0.28%
IMTX ExitIMMATICS N.V$0-152,990
-100.0%
-0.30%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-81,627
-100.0%
-0.36%
VMC ExitVULCAN MATLS CO$0-12,647
-100.0%
-0.37%
MLM ExitMARTIN MARIETTA MATLS INC$0-8,057
-100.0%
-0.48%
EPAM ExitEPAM SYS INC$0-6,500
-100.0%
-0.56%
YNDX ExitYANDEX N V$0-55,000
-100.0%
-0.65%
MELI ExitMERCADOLIBRE INC$0-2,500
-100.0%
-0.65%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-135,907
-100.0%
-0.76%
DMYI ExitDMY TECHNOLOGY GROUP INC III$0-426,732
-100.0%
-0.77%
KRYS ExitKRYSTAL BIOTECH INC$0-70,274
-100.0%
-0.80%
BBIO ExitBRIDGEBIO PHARMA INC$0-80,384
-100.0%
-0.82%
RCKT ExitROCKET PHARMACEUTICALS INC$0-140,270
-100.0%
-1.04%
SNPR ExitTORTOISE ACQUISITION CORP II$0-635,912
-100.0%
-1.07%
DCRB ExitDECARBONIZATION PLUS ACQU CO$0-709,849
-100.0%
-1.23%
CCIV ExitCHURCHILL CAPITAL CORP IVcl a$0-330,325
-100.0%
-1.60%
AONE ExitONE$0-993,561
-100.0%
-1.66%
AON ExitAON PLC$0-42,000
-100.0%
-1.68%
CSTM ExitCONSTELLIUM SE$0-675,000
-100.0%
-2.15%
AMZN ExitAMAZON COM INC$0-4,300
-100.0%
-2.48%
AEVA ExitAEVA TECHNOLOGIES INC$0-1,500,000
-100.0%
-2.66%
INTU ExitINTUIT$0-43,500
-100.0%
-3.58%
PTON ExitPELOTON INTERACTIVE INC$0-180,000
-100.0%
-3.75%
MU ExitMICRON TECHNOLOGY INC$0-265,965
-100.0%
-3.80%
NCR ExitNCR CORP NEW$0-654,631
-100.0%
-5.02%
EXPE ExitEXPEDIA GROUP INC$0-230,000
-100.0%
-6.32%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMAZON COM INC16Q2 20219.8%
ACTIVISION BLIZZARD INC15Q3 202012.9%
ALPHABET INC15Q3 202110.0%
YANDEX N V14Q2 20214.6%
KITE PHARMA INC13Q3 20176.1%
ALIBABA GROUP HLDG LTD13Q3 20206.3%
ALLOGENE THERAPEUTICS INC12Q3 20213.6%
MICROSOFT CORP11Q3 202110.3%
ELECTRONIC ARTS INC11Q2 20189.2%
ANTHEM INC11Q1 202012.5%

View DSAM Partners (London) Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR/A2020-11-18
13F-HR/A2020-11-18
13F-HR/A2020-11-18
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR/A2020-05-15

View DSAM Partners (London) Ltd's complete filings history.

Compare quarters

Export DSAM Partners (London) Ltd's holdings